TIAA FSB’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$2.9M Sell
37,616
-2,948
-7% -$235K 0.01% 234
2023
Q1
$3.37M Sell
40,564
-9,211
-19% -$763K 0.01% 221
2022
Q4
$4.27M Sell
49,775
-164,417
-77% -$13M 0.02% 209
2022
Q3
$13.2M Sell
214,192
-6,062
-3% -$382K 0.06% 138
2022
Q2
$13.6M Buy
220,254
+183,732
+503% +$11.4M 0.05% 142
2022
Q1
$2.14M Sell
36,522
-1,308
-3% -$83.6K 0.01% 252
2021
Q4
$2.71M Sell
37,830
-4,249
-10% -$293K 0.01% 230
2021
Q3
$2.94M Buy
42,079
+2,156
+5% +$151K 0.01% 225
2021
Q2
$2.75M Buy
39,923
+814
+2% +$54.4K 0.01% 232
2021
Q1
$2.53M Buy
39,109
+354
+0.9% +$22.8K 0.01% 225
2020
Q4
$2.26M Sell
38,755
-203
-0.5% -$12.2K 0.01% 232
2020
Q3
$2.46M Buy
38,958
+1,481
+4% +$103K 0.01% 206
2020
Q2
$2.88M Buy
37,477
+1,152
+3% +$88.3K 0.01% 199
2020
Q1
$2.71M Sell
36,325
-1,611
-4% -$111K 0.02% 191
2019
Q4
$2.46M Buy
37,936
+886
+2% +$57.7K 0.01% 220
2019
Q3
$2.35M Sell
37,050
-2,864
-7% -$187K 0.01% 212
2019
Q2
$2.7M Sell
39,914
-96,209
-71% -$6.33M 0.01% 195
2019
Q1
$8.85M Sell
136,123
-11,858
-8% -$788K 0.07% 120
2018
Q4
$9.26M Buy
147,981
+33,309
+29% +$2.33M 0.05% 111
2018
Q3
$8.85M Buy
114,672
+73,404
+178% +$5.54M 0.05% 119
2018
Q2
$2.92M Buy
41,268
+536
+1% +$37.9K 0.02% 196
2018
Q1
$3.07M Sell
40,732
-2,555
-6% -$203K 0.02% 192
2017
Q4
$3.1M Sell
43,287
-4,544
-10% -$345K 0.02% 210
2017
Q3
$3.88M Sell
47,831
-1,728
-3% -$132K 0.02% 180
2017
Q2
$3.51M Buy
+49,559
New +$3.3M 0.02% 176

Other funds holding GILD

TIAA FSB's GILD Position: Q2 2023 in Review

TIAA FSB reduced its Gilead Sciences (GILD) stake by 7.3% in Q2 2023, selling an estimated $235K and leaving 37,616 shares worth $2.9M. The position accounts for 0.01% of the portfolio, ranked #234.

TIAA FSB first reported a position in GILD in Q2 2017 and has held it in 25 quarters since. The position peaked at $13.6M in Q2 2022. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • TIAA FSB held 37,616 shares of Gilead Sciences worth $2.9M as of Q2 2023.
  • TIAA FSB sold 2,948 Gilead Sciences shares in Q2 2023, an estimated $235K.
  • Gilead Sciences made up 0.01% of TIAA FSB's portfolio in Q2 2023, its #234 holding.
  • TIAA FSB first reported a position in Gilead Sciences in Q2 2017 and has held it in 25 quarters since.
  • TIAA FSB's Gilead Sciences position peaked at $13.6M in Q2 2022.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.